$ALNY ALNYLAM PHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ALNYLAM PHARMACEUTICALS, INC. for free.

CIK Number: 0001178670
IRS Number: 770602661
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ALNY
Company Address: 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE 02142
Former name: ALNYLAM PHARMACEUTICALS INC, date of change: 2002-07-24

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's products include ONPATTRO, GIVLAARI, and OXLUMO. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Market Capitalization: $3.49B
Prev close: $40.46
Average Daily Volume: 1,254,630
Days Low: $39.66
Year Low: $31.38
Year High: $80.11

ALNYLAM PHARMACEUTICALS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Greenstreet YvonnePresident & COO13,374541,112shares bought: 172,193 / shares sold: -164,234 BUYApr 21 202115 days ago
KEATING LAURIEEVP, Chief Legal Officer8,955362,319shares bought: 191,024 / shares sold: -195,081 SELLApr 21 202115 days ago
MARAGANORE JOHNChief Executive Officer222,2728,993,125shares bought: 699,499 / shares sold: -626,397 BUYApr 21 202115 days ago
Poulton Jeffrey V.Chief Financial Officer4,518182,798shares bought: 4,575 / shares sold: -1,383 STRONG BUYApr 21 202115 days ago
Vaishnaw AkshayPresident, R&D22,908926,858shares bought: 281,829 / shares sold: -273,283 BUYApr 21 202115 days ago

View all ALNYLAM PHARMACEUTICALS, INC. insiders.

ALNYLAM PHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS138.4810714,81714,11914.2 K to 14.1 K (-0.75 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS137.6053072,92814,22614.8 K to 14.2 K (-3.59 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS136.841,892258,90114,75616.6 K to 14.8 K (-11.36 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS135.4120327,48816,64816.9 K to 16.6 K (-1.20 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DPayment of ExerciseF134.568511,43816,85116.9 K to 16.9 K (-0.50 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DPayment of ExerciseF131.752,266298,54616,93619.2 K to 16.9 K (-11.80 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS140.0241758,38819,20219.6 K to 19.2 K (-2.13 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS138.6462286,23419,61920.2 K to 19.6 K (-3.07 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS137.60989136,08620,24121.2 K to 20.2 K (-4.66 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DSellS136.761,678229,48321,23022.9 K to 21.2 K (-7.32 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Vaishnaw AkshayPresident, R&DGrantA0.005,083022,90817.8 K to 22.9 K (+28.52 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Poulton Jeffrey V.Chief Financial Off ...BuyJ0.00380380 to 38
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Poulton Jeffrey V.Chief Financial Off ...Payment of ExerciseF134.49506,7253,1353.2 K to 3.1 K (-1.57 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Poulton Jeffrey V.Chief Financial Off ...Payment of ExerciseF131.751,333175,6233,1854.5 K to 3.2 K (-29.50 %)
Apr 21 2021ALNYALNYLAM PHARMACEUT ...Poulton Jeffrey V.Chief Financial Off ...GrantA0.004,51804,5180 to 4.5 K

View all ALNYLAM PHARMACEUTICALS, INC. insider transactions.